Evvy is bringing everyday issues to light.
What’s happening: The digital vaginal health platform launched an AI-powered advisor to advance its microbiome care offering.
Microbiome model. Launched in 2021, Evvy provides at-home vaginal microbiome testing and care spanning prescriptions, OTCs, supplements, and telehealth. With the majority of women experiencing vaginal dysbiosis in their lifetime, it addresses common conditions like yeast infections, bacterial vaginosis, and UTIs.
Completing 100K+ tests to date, the company will tap what it claims is the largest proprietary vaginal microbiome dataset available, training EvvyAI to translate test results into personalized action items for vaginal imbalances, but also fertility and menopause, directing patients to clinicians as needed.
Data-powered. Trained on male-centric data, generic chatbots increasingly misdiagnose women’s health concerns. Addressing the gender care gap, targeted LLMs are emerging, along with a consortium to oversee and verify AI-enabled care.
A moat, with women’s medical research underindexed, platforms with clinical specialties and diagnostics layers gain contextualized feedback other bots can’t copy.
Punchline: Maximizing its proprietary data, Evvy is taking vaginal health out of the OB-GYN office with personalized, real-time guidance.
